Dan Sunnemark

Publications
Public outreach and news

Articles

Article: SYNAPSE. 2023;77(4):e22269
[¹¹C]PBB3 binding in Aβ(-) or Aβ(+) corticobasal syndrome
Cselenyi Z; Wallin J; Tjerkoski J; Bloth B; Svensson S; Nennesmo I; Sunnemark D; Jelic V; Farde L; Svenningsson P
Article: MOLECULAR AND CELLULAR NEUROSCIENCE. 2021;114:103641
Elevated soluble amyloid beta protofibrils in Down syndrome and Alzheimer's disease
Johannesson M; Sahlin C; Soderberg L; Basun H; Falting J; Moller C; Zachrisson O; Sunnemark D; Svensson A; Odergren T; Lannfelt L
Article: BRAIN RESEARCH. 2020;1749:147131
Identification and in vitro characterization of C05-01, a PBB3 derivative with improved affinity for alpha-synuclein
Miranda-Azpiazu P; Svedberg M; Higuchi M; Ono M; Jia Z; Sunnemark D; Elmore CS; Schou M; Varrone A
Article: CELL AND TISSUE RESEARCH. 2017;369(3):445-454
Myeloperoxidase-immunoreactive cells are significantly increased in brain areas affected by neurodegeneration in Parkinson's and Alzheimer's disease
Gellhaar S; Sunnemark D; Eriksson H; Olson L; Galter D
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2014;111(14):5409-5414
Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis
Wollberg AR; Ericsson-Dahlstrand A; Jureus A; Ekerot P; Simon S; Nilsson M; Wiklund S-J; Berg A-L; Ferm M; Sunnemark D; Johansson R
Article: ACTA NEUROPATHOLOGICA COMMUNICATIONS. 2014;2:22
MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer's disease granulovacuolar degeneration bodies
Lund H; Gustafsson E; Svensson A; Nilsson M; Berg M; Sunnemark D; von Euler G
Article: NEUROMOLECULAR MEDICINE. 2013;15(3):458-469
Role of Individual MARK Isoforms in Phosphorylation of Tau at Ser²⁶² in Alzheimer's Disease
Gu GJ; Lund H; Wu D; Blokzijl A; Classon C; von Euler G; Landegren U; Sunnemark D; Kamali-Moghaddam M
Article: BRAIN PATHOLOGY. 2013;23(4):378-389
Tau-Tubulin Kinase 1 Expression, Phosphorylation and Co-Localization with Phospho-Ser422 Tau in the Alzheimer's Disease Brain
Lund H; Cowburn RF; Gustafsson E; Stromberg K; Svensson A; Dahllund L; Malinowsky D; Sunnemark D
Article: JOURNAL OF ALZHEIMER'S DISEASE. 2013;33(3):699-713
Elevated MARK2-Dependent Phosphorylation of Tau in Alzheimer's Disease
Gu GJ; Wu D; Lund H; Sunnemark D; Kvist AJ; Milner R; Eckersley S; Nilsson LNG; Agerman K; Landegren U; Kamali-Moghaddam M
Journal article: ALZHEIMER'S AND DEMENTIA. 2011;7(4S_Part_20):s707
P4‐028: The expression of TGM2 in the Alzheimer brain is restricted to blood vessels
Lund H; Svensson A; Nilsson M; Sunnemark D
Article: JOURNAL OF NEUROCHEMISTRY. 2010;114(3):784-794
Characterization of AZD4694, a novel fluorinated Aβ plaque neuroimaging PET radioligand
Jureus A; Swahn B-M; Sandell J; Jeppsson F; Johnson AE; Johnstrom P; Neelissen JAM; Sunnemark D; Farde L; Svensson SPS
Article: NEUROBIOLOGY OF AGING. 2008;29(9):1423-1433
Age related changes in brain metabolites observed by ¹H MRS in APP/PS1 mice
Oberg J; Spenger C; Wang F-H; Andersson A; Westman E; Skoglund P; Sunnemark D; Norinder U; Klason T; Wahlund L-O; Lindberg M
Article: JOURNAL OF NEUROINFLAMMATION. 2007;4:14
Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: Insight into mechanisms of MOG-induced EAE
Eltayeb S; Berg A-L; Lassmann H; Wallstrom E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D
Article: JOURNAL OF NEUROINFLAMMATION. 2005;2:17
CX₃CL1 (fractalkine) and CX₃CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin
Sunnemark D; Eltayeb S; Nilsson M; Wallstrom E; Lassmann H; Olsson T; Berg A-L; Ericsson-Dahlstrand A
Article: BRAIN PATHOLOGY. 2003;13(4):617-629
Differential expression of the chemokine receptors CX₃CR1 and CCR1 by microglia and macrophages in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis
Sunnemark D; Eltayeb S; Wallström E; Appelsved L; Malmberg Å; Lassmann H; Ericsson-Dahlstrand A; Piehl F; Olsson T
Article: PROTEOMICS. 2003;3(10):1920-1929
Dihydropyrimidinase related protein-2 as a biomarker for temperature and time dependent post mortem changes in the mouse brain proteome
Franzén B; Yang Y; Sunnemark D; Wickman M; Ottervald J; Oppermann M; Sandberg K
Article: JOURNAL OF NEUROIMMUNOLOGY. 2003;142(1-2):75-85
Effector stage CC chemokine receptor-1 selective antagonism reduces multiple sclerosis-like rat disease
Eltayeb S; Sunnemark D; Berg AL; Nordvall G; Malmberg Å; Lassmann H; Wallström E; Olsson T; Ericsson-Dahlstrand A
Article: IMMUNOLOGY LETTERS. 2003;86(2):207-212
Chronic murine Chagas' disease:: the impact of host and parasite genotypes
Andersson J; Örn A; Sunnemark D
Article: MUSCLE AND NERVE. 2003;27(4):442-448
CBA/J mice infected with Trypanosoma cruzi:: An experimental model for inflammatory myopathies
Andersson J; Englund P; Sunnemark D; Dahlstedt A; Westerblad H; Nennesmo I; Örn A; Lundberg IE
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2001;121(3):499-505
Enhancement of natural killer (NK) cell cytotoxicity and induction of NK cell-derived interferon-gamma (IFN-γ) display different kinetics during experimental infection with Trypanosoma cruzi
Une C; Andersson J; Eloranta ML; Sunnemark D; Harris RA; Örn A
Article: ATHEROSCLEROSIS. 2000;153(2):273-282
Induction of early atherosclerosis in CBA/J mice by combination of Trypanosoma cruzi infection and a high cholesterol diet
Sunnemark D; Harris RA; Frostegård J; Örn A
Article: INFECTION AND IMMUNITY. 1999;67(4):1789-1797
Rapid local expression of interleukin-12, tumor necrosis factor alpha, and gamma interferon after cutaneous Francisella tularensis infection in tularemia-immune mice
Stenmark S; Sunnemark D; Bucht A; Sjöstedt A
Journal article: INFECTION AND IMMUNITY. 1999;67(4):1789-1797
Rapid Local Expression of Interleukin-12, Tumor Necrosis Factor Alpha, and Gamma Interferon after CutaneousFrancisella tularensis Infection in Tularemia-Immune Mice
Stenmark S; Sunnemark D; Bucht A; Sjöstedt A
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1998;48(5):480-484
Cellular and cytokine characterization of vascular inflammation in CBA/J mice chronically infected with Trypanosoma cruzi
Sunnemark D; Frostegård J; Örn A; Harris RA
Article: IMMUNOLOGY LETTERS. 1998;60(2-3):171-177
Enhanced prevalence of T cells expressing TCRBV8S2 and TCRBV8S3 in hearts of chronically Trypanosoma cruzi-infected mice
Sunnemark D; Andersson R; Harris RA; Jeddi-Tehrani M; Örn A
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1996;44(5):421-429
Cytokine production in hearts of Trypanosoma cruzi-infected CBA mice: Do cytokine patterns in chronic stage reflect the establishment of myocardial pathology?
Sunnemark D; Ulfgren AK; Orn A; Harris RA
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1996;44(2):122-128
Detection of cruzipain, the major cysteine proteinase from Trypanosoma cruzi and its C-terminal extension in biological fluids during experimental infection in mice
Gonzalez G; Sunnemark D; Orn A; Gronvik KO
Journal article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1993;37(5):559-568
ORGAN-SPECIFIC REGULATION OF INTERFERON-GAMMA, INTERLEUKIN-2 AND INTERLEUKIN-2 RECEPTOR DURING MURINE INFECTION WITH TRYPANOSOMA-CRUZI
ROTTENBERG ME; SUNNEMARK D; LEANDERSSON T; ORN A
Show more

All other publications

Conference publication: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2020;47(SUPPL 1):S117
Identification and in vitrocharacterization of C05-01, a PPB3 derivative with improved affinity for α-synuclein
Azpiazu PM; Svedberg M; Higuchi M; Ono M; Jia Z; Sunnemark D; Elmore C; Schou M; Varrone A
Review: JOURNAL OF LEUKOCYTE BIOLOGY. 2008;84(5):1248-1255
Pivotal Advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis
Andersson A; Covacu R; Sunnemark D; Danilov AI; Dal Bianco A; Khademi M; Wallstrom E; Lobell A; Brundin L; Lassmann H; Harris RA
Review: BIOMÉDICA: REVISTA DEL INSTITUTO NACIONAL DE SALUD. 2003;23(4):462-475
[Neurological effects of American trypanosomyiasis: clinical aspects].
León-Sarmiento FE; Prada DG; Bayona-Prieto J; Valderrama V; García I; León ME; Sunnemark D
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2000;43(9):S196
CBA/J mice infected with Trypanosoma cruzi as an experimental model for human polymyositis.
Nyberg P; Andersson J; Sunnemark D; Dahlstedt A; Westerblad H; Nennesmo I; Orn A; Lundberg I
Thesis / dissertation: 1998
Immunopathogenesis of experimental Chagas' disease
Sunnemark, Dan
Conference publication: EUROPEAN CYTOKINE NETWORK. 1998;9(3):398
Cytokine production in chronic stage Trypanosoma cruzi-infected CBA mice
Harris RA; Sunnemark D; Frostegård J; Örn A
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1992;36(4):637
EXPRESSION OF IL-2, IL-2R AND IFN-GAMMA DURING TRYPANOSOMA-CRUZI INFECTION
ORN A; SUNNEMARK D; ROTTENBERG M

Articles

All other publications

News from KI

Events from KI